[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Vista Partners LLC [@VistaPResearch](/creator/twitter/VistaPResearch) on x 7399 followers Created: 2025-07-21 04:14:09 UTC During the Phase 2b portion of the RESOLVE study, Eupraxia will continue to report additional data from patients that were entered into the open-label Phase 2a study, with further data from cohorts 5–8 available in early September & November of 2025 $EPRX  XX engagements  **Related Topics** [$eprx](/topic/$eprx) [vista](/topic/vista) [Post Link](https://x.com/VistaPResearch/status/1947148063283495265)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Vista Partners LLC @VistaPResearch on x 7399 followers
Created: 2025-07-21 04:14:09 UTC
During the Phase 2b portion of the RESOLVE study, Eupraxia will continue to report additional data from patients that were entered into the open-label Phase 2a study, with further data from cohorts 5–8 available in early September & November of 2025 $EPRX
XX engagements
/post/tweet::1947148063283495265